Close Menu

NEW YORK (360Dx) – Quidel said on Tuesday that the US Food and Drug Administration has granted 510(k) clearance for its fluorescence immunoassay test, the Triage TOX Drug Screen, 94600, which simultaneously detects different drug metabolites in urine.

The test, cleared for use with Quidel's Triage MeterPro instrument, uses monoclonal antibodies that are specific for the metabolites of nine drug classes, Quidel said.

The speed and sensitivity of immunoassays have made them "the most accepted method for screening urine for the presence of drugs," the firm noted in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.